journal article·2023-07

Photophysical properties of Pt(II) and Pd(II) complexes for two-photon photodynamic therapy: A computational investigation

Xue Wei, Wei-Bo Cui, Feng-Yi Sun, Hui Li, Jing-Fu Guo, Xue-Li Hao, Ai-Min Ren

Dyes and Pigments· Volume 215
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nonlinear Optical Materials Studies · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
2. Features of third generation photosensitizers used in anticancer photodynamic therapy: review10.1016/j.pdpdt.2020.102091 ↗
3. Clinical development and potential of photothermal and photodynamic therapies for cancer. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
4. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
5. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
6. Water-soluble nanoparticles with twisted double[7]Carbohelicene for lysosome-targeted cancer photodynamic therapy
7. Theoretical exploration of the photophysical properties of two-component RuII-porphyrin dyes as promising assemblies for a combined antitumor effect10.1039/D0DT02197K ↗
8. Theoretical investigation on bisarylselanylbenzo-2,1,3-selenadiazoles as potential photosensitizers in photodynamic therapy10.1063/5.0038326 ↗
9. Iodine substituted phosphorus corrole complexes as possible photosensitizers in photodynamic therapy: insights from theory10.1002/jcc.26183 ↗
10. Activation by glutathione in hypoxic environment of an azo-based rhodamine activatable photosensitizer. A computational elucidation10.1002/chem.202104083 ↗
11. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer10.1039/C9CS00129H ↗
12. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review10.1039/D1CS00609F ↗
13. Coordination complexes as a new generation photosensitizer for photodynamic anticancer therapy10.3390/ijms22158052 ↗
14. Versatile strategy to generate a rhodamine triplet state as mitochondria-targeting visible-light photosensitizers for efficient photodynamic therapy10.1021/acsami.8b20224 ↗
15. Rationally designed long-wavelength absorbing Ru(II) polypyridyl complexes as photosensitizers for photodynamic therapy10.1021/jacs.9b13620 ↗
16. Visible-light-induced annihilation of tumor cells with platinum-porphyrin conjugates10.1002/anie.201400533 ↗
17. Two-photon small-molecule fluorescence-based agents for sensing, imaging, and therapy within biological systems10.1039/D0CS00861C ↗
18. Two-photon excitation nanoparticles for photodynamic therapyt10.1039/C6CS00442C ↗
19. A valproic acid-modified platinum diimine complex as potential photosensitizer for photodynamic therapy10.1016/j.jinorgbio.2021.111508 ↗
20. Photophysical exploration of dual-approach Pt-II-BODIPY conjugates: theoretical insights10.1021/acs.inorgchem.9b01002 ↗
21. A platinum(II) complex of heptamethine cyanine for photoenhanced cytotoxicity and cellular imaging in near-IR light10.1002/anie.201806911 ↗
22. Platinum-based two-photon photosensitizer responsive to NIR light in tumor hypoxia microenvironment10.1021/acs.jmedchem.2c00141 ↗
23. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal10.1039/c9pp00363k ↗
24. Photodynamic effect of palladium porphyrin derived from cashew nut shell liquid against promastigote forms of Leishmania braziliensis10.1016/j.pdpdt.2020.102083 ↗
25. Investigation of powerful fungicidal activity of tetra-cationic platinum(II) and palladium(II) porphyrins by antimicrobial photodynamic therapy assays10.1016/j.pdpdt.2021.102550 ↗
26. Pawłowski, F.; Ortiz, J. Electron propagator calculations of vertical electron binding energies and dyson orbitals in Gaussian16.
27. Two-photon absorption in solution by means of time-dependent density-functional theory and the polarizable continuum model10.1063/1.1944727 ↗
28. Quantum mechanical continuum solvation models for ionic liquids10.1021/jp304365v ↗
29. Evaluation of spin-orbit couplings with linear-response time-dependent density functional methods10.1021/acs.jctc.6b00915 ↗
30. A multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
31. Vmd: visual molecular dynamics10.1016/0263-7855(96)00018-5 ↗
32. The Dalton quantum chemistry program system10.1002/wcms.1172 ↗
33. Benchmarking two-photon absorption cross sections: performance of CC2 and CAM-B3LYP10.1039/C5CP03241E ↗
34. Multiphoton spectroscopy10.1146/annurev.pc.18.100167.001313 ↗
35. Theoretical exploration of type I/type II dual photoreactivity of promising Ru(II) dyads for PDT approach10.1021/acs.inorgchem.6b01782 ↗
36. A theoretical investigation into the luminescent properties of d8-transition-metal complexes with tetradentate schiff base ligands10.1002/chem.201304375 ↗
37. Theoretical investigation of the effect of alkylation and bromination on intersystem crossing in BODIPY-based photosensitizers10.1021/acs.jpcb.1c05236 ↗
38. Activation by glutathione in hypoxic environment of an azo-based rhodamine activatable photosensitizer. A computational elucidation10.1002/chem.202104083 ↗
39. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory10.1039/c3cp52698d ↗
40. Spin–orbit coupling and intersystem crossing in molecules10.1002/wcms.83 ↗
41. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
42. Cationization-enhanced type I and type II ROS generation for photodynamic treatment of drug-resistant bacteria10.1021/acsnano.2c01206 ↗
43. Theoretical investigation on bisarylselanylbenzo-2,1,3-selenadiazoles as potential photosensitizers in photodynamic therapy10.1063/5.0038326 ↗
44. Recent development of the transition metal complexes showing strong absorption of visible light and long-lived triplet excited state: from molecular structure design to photophysical properties and applications10.1016/j.ccr.2020.213371 ↗
45. Theoretical exploration of the photophysical properties of two-component RuII–porphyrin dyes as promising assemblies for a combined antitumor effect10.1039/D0DT02197K ↗
46. Oncologic photodynamic therapy: basic principles, current clinical status and future directions10.3390/cancers9020019 ↗